142 related articles for article (PubMed ID: 35243036)
1. A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence.
Chuter R; Glassborow E; Speight R; Clarke M; Murray L; Radhakrishna G; Lavin V; Aspin L; Aldred M; Gregory S; Richardson J; Handley J
Phys Imaging Radiat Oncol; 2022 Jan; 21():78-83. PubMed ID: 35243036
[TBL] [Abstract][Full Text] [Related]
2. Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors.
Lischalk JW; Chen H; Repka MC; Campbell LD; Obayomi-Davies O; Kataria S; Kole TP; Rudra S; Collins BT
Adv Radiat Oncol; 2018; 3(3):447-457. PubMed ID: 30202812
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Regnery S; Leiner L; Buchele C; Hoegen P; Sandrini E; Held T; Deng M; Eichkorn T; Rippke C; Renkamp CK; König L; Lang K; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2023 May; 18(1):92. PubMed ID: 37248504
[TBL] [Abstract][Full Text] [Related]
4. Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer.
Slevin F; Thompson CM; Speight R; Murray LJ; Lilley J; Henry AM
Med Dosim; 2021 Winter; 46(4):411-418. PubMed ID: 34148727
[TBL] [Abstract][Full Text] [Related]
5. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
6. Conventionally fractionated large volume head and neck re-irradiation using multileaf collimator-based robotic technique: A feasibility study.
Bahig H; Wang C; Ping Ng S; Phan J
Clin Transl Radiat Oncol; 2020 Sep; 24():102-110. PubMed ID: 32715109
[TBL] [Abstract][Full Text] [Related]
7. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
8. Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer.
Robinson M; O'Cathail S; Duffton A; Aitken K; Muirhead R
Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):571-577. PubMed ID: 35504797
[TBL] [Abstract][Full Text] [Related]
9. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
Devlin L; Dodds D; Sadozye A; McLoone P; MacLeod N; Lamb C; Currie S; Thomson S; Duffton A
Br J Radiol; 2020 Apr; 93(1108):20190789. PubMed ID: 31971829
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
Chi A; Liao Z; Nguyen NP; Xu J; Welsh JS; Jang SY; Howe C; Komaki R
PLoS One; 2012; 7(4):e35809. PubMed ID: 22558228
[TBL] [Abstract][Full Text] [Related]
12. Can reducing planning safety margins broaden the inclusion criteria for lung stereotactic ablative body radiotherapy?
Ghandourh W; Batumalai V; Boxer M; Holloway L
J Med Radiat Sci; 2021 Sep; 68(3):298-309. PubMed ID: 33934559
[TBL] [Abstract][Full Text] [Related]
13. To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.
Kim J; Wu Q; Zhao B; Wen N; Ajlouni M; Movsas B; Chetty IJ
Radiat Oncol; 2016 Sep; 11(1):125. PubMed ID: 27659780
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
15. Proton beam therapy in rectal cancer: A systematic review and meta-analysis.
Fok M; Toh S; Easow J; Fowler H; Clifford R; Parsons J; Vimalachandran D
Surg Oncol; 2021 Sep; 38():101638. PubMed ID: 34340196
[TBL] [Abstract][Full Text] [Related]
16. Proton versus Photon Breath-Hold Radiation for Left-Sided Breast Cancer after Breast-Conserving Surgery: A Dosimetric Comparison.
Mondal D; Jhawar SR; Millevoi R; Haffty BG; Parikh RR
Int J Part Ther; 2021; 7(3):24-33. PubMed ID: 33604413
[TBL] [Abstract][Full Text] [Related]
17. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
20. Dose-Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant Metastasis.
Raturi VP; Tochinai T; Hojo H; Rachi T; Hotta K; Nakamura N; Zenda S; Motegi A; Ariji T; Hirano Y; Baba H; Ohyoshi H; Nakamura M; Okumura M; Bei Y; Akimoto T
Front Oncol; 2020; 10():517061. PubMed ID: 33194580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
